tiprankstipranks
Exelixis (EXEL)
NASDAQ:EXEL
US Market
EXEL
Exelixis
RESEARCH TOOLSreports

Exelixis (EXEL) Stock News & Sentiment

3,148 Followers
Hold Rating on Exelixis Amid Emerging Belzutifan Competition and Uncertain Cabo Revenue Visibility
Premium
Ratings
Hold Rating on Exelixis Amid Emerging Belzutifan Competition and Uncertain Cabo Revenue Visibility
1M ago
EXEL
Exelixis: Welireg Competition Tempers RCC Upside but Embedded Cabozantinib Franchise Supports Hold Rating
Premium
Ratings
Exelixis: Welireg Competition Tempers RCC Upside but Embedded Cabozantinib Franchise Supports Hold Rating
1M ago
EXEL
Crocs, Linde, Zillow, Exelixis, Qorvo: Insider Cash-Outs
Premium
Weekend Updates
Crocs, Linde, Zillow, Exelixis, Qorvo: Insider Cash-Outs
1M ago
Z
LIN
Exelixis: Solid Financial Beat and Advancing Oncology Pipeline Drive Upgraded Earnings Outlook and $54 Price Target
Premium
Ratings
Exelixis: Solid Financial Beat and Advancing Oncology Pipeline Drive Upgraded Earnings Outlook and $54 Price Target
2M ago
EXEL
Exelixis Earnings Call: CABOMETYX Strength, ZANZA Catalyst
Premium
Company Announcements
Exelixis Earnings Call: CABOMETYX Strength, ZANZA Catalyst
2M ago
EXEL
Exelixis: Solid Q4 Execution and Advancing Pipeline Underpin Buy Rating and 2026 Earnings Power
Premium
Ratings
Exelixis: Solid Q4 Execution and Advancing Pipeline Underpin Buy Rating and 2026 Earnings Power
2M ago
EXEL
Exelixis (EXEL) Q4 Earnings Cheat Sheet
Premium
Pre-Earnings
Exelixis (EXEL) Q4 Earnings Cheat Sheet
2M ago
EXEL
More EXEL News >

EXEL News on the Web

Exelixis (EXEL) Gets a Hold from RBC Capital
TipRanks News
Bearish
Exelixis (EXEL) is a Top-Ranked Value Stock: Should You Buy?
Zacks
Bullish
Wells Fargo Sticks to Its Hold Rating for Exelixis (EXEL)
TipRanks News
Bearish
Here's Why Exelixis (EXEL) is a Strong Growth Stock
Zacks
Neutral
Exelixis: A Strong Contender in the Cancer Drug Market
The Motley Fool
Bearish
Jefferies Sticks to Its Buy Rating for Exelixis (EXEL)
TipRanks News
Neutral
Recursion Pharmaceuticals announces Vicki Goodman as chief medical officer
TipRanks News
Neutral
Here's Why Exelixis (EXEL) is a Strong Value Stock
Zacks
Neutral

News Score - Last 7 Days

Neutral
EXEL
Sector Average
Media Buzz
This Week2 articles
Weekly Average2 articles
News Sentiment
This Week50%
Sector Average69%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is EXEL’s Media Buzz Sentiment?
2 articles about EXEL were published this week. In an average week, 2 articles are published.
    What is EXEL’s weekly average amount of articles?
    In an average week, 2 articles about EXEL are published.
      What is EXEL’s News Sentiment?
      50% of articles about EXEL were positive this week, compared to its sector average of 69%.
        Healthcare Stocks that are Trending in the News
        NBIXNeurocrine
        STAAStaar Surgical
        AORTArtivion
        OWLTOwlet
        HUMHumana
        Showing the stocks with the most bullish news sentiment over the past week